QA: LIXTE BIOTECHNOLOGY HOLDINGS INC. in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001335105_2021_LIXTE_BIOTECHNOLOGY_HOLDINGS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001335105')"}

Graph

Absolute values for 0001335105, LIXTE BIOTECHNOLOGY HOLDINGS INC.

  xvar xval
0 AssetsCurrent 5,228,475
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 216,524
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,042,764
9 ResearchAndDevelopmentExpense 1,223,676
10 remainder_Expenses 3,674
11 remainder_Revenues 0
12 remainder_NetIncome 5,232
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 5,228,475
1 Liabilities 216,524
2 Expenses 3,270,114
3 Revenues 0
4 StockholdersEquity 5,011,951
5 NetIncome -3,264,882
6 ComprehensiveNetIncome -3,264,882
7 BaseVar 4,360,172
8 EconomicCapitalRatio 1.97

Edgar->Model Mapping

Feature Distribution

Change over Time